Marty Makary
speaker
939 appearances
6 recordings
5 series
first heard Jan 2026
last heard 13 May
Marty Makary’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 6 in all, peaking in Jan 2026 with 4.
Appearances
that today are looking at papers on cell and gene therapies, early data, and they're saying, when can I get access?
I'm at risk.
This matters a lot to patients.
And maybe you can help contextualize how this translates into speed and access.
Right.
And what about for CAR T therapy?
So there's this blossoming class of therapeutics in CAR T that's historically been used exclusively for oncology, for cancer, increasing discussion about using it for autoimmune conditions.
Does this help with the CAR T therapy pathway and enabling faster routes to market and more access and lower cost?
And just for folks to understand when they take T cells, edit them and put them back in the body and those T cells go after targets in the body and destroy those targets and many blood cancers are now seeing extraordinary results with these CAR T therapies and now they're going after autoimmune conditions.
But it definitely seems to be that there needs to be a faster path to market lower cost because the pricing is half a million to a million dollars still.
What else have you discovered since you've been in the FDA that shocked you?
Let's just go on and aside for a second.
I'm curious to know what are the biggest shocks that you've uncovered?
I mean, you've now been there for some time.
You mentioned before we sat down that you're actively digitizing millions of files that historically have not been digitized.
And I'm assuming you can now use AI and other tools to go read through them very quickly.
What's been shocking to you?
each center of the FDA.
Each center of the FDA.
Same agency.
Showing 461–480 of 939 · page 24 of 47
← Previous
Next →